IVEDA SOLUTIONS INC (IVDA)

US46583A2042 - Common Stock

0.9185  +0.02 (+1.74%)

Premarket: 0.9499 +0.03 (+3.42%)

Fundamental Rating

3

Taking everything into account, IVDA scores 3 out of 10 in our fundamental rating. IVDA was compared to 276 industry peers in the Software industry. The financial health of IVDA is average, but there are quite some concerns on its profitability. IVDA is valued quite expensively, but it does show have an excellent growth rating.



0

1. Profitability

1.1 Basic Checks

IVDA had negative earnings in the past year.
IVDA had a negative operating cash flow in the past year.
IVDA had negative earnings in each of the past 5 years.
IVDA had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

IVDA has a Return On Assets of -44.60%. This is amonst the worse of the industry: IVDA underperforms 80.66% of its industry peers.
With a Return On Equity value of -54.88%, IVDA is not doing good in the industry: 66.42% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -44.6%
ROE -54.88%
ROIC N/A
ROA(3y)-59.62%
ROA(5y)-73.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IVDA has a Gross Margin of 16.44%. This is amonst the worse of the industry: IVDA underperforms 85.77% of its industry peers.
In the last couple of years the Gross Margin of IVDA has declined.
IVDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.82%
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

IVDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVDA has more shares outstanding
IVDA has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.61, we must say that IVDA is in the distress zone and has some risk of bankruptcy.
IVDA's Altman-Z score of -2.61 is on the low side compared to the rest of the industry. IVDA is outperformed by 79.93% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that IVDA is not too dependend on debt financing.
IVDA has a Debt to Equity ratio (0.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -2.61
ROIC/WACCN/A
WACC9.79%

2.3 Liquidity

IVDA has a Current Ratio of 4.06. This indicates that IVDA is financially healthy and has no problem in meeting its short term obligations.
IVDA has a Current ratio of 4.06. This is amongst the best in the industry. IVDA outperforms 83.21% of its industry peers.
A Quick Ratio of 3.84 indicates that IVDA has no problem at all paying its short term obligations.
IVDA's Quick ratio of 3.84 is amongst the best of the industry. IVDA outperforms 81.75% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.84

8

3. Growth

3.1 Past

IVDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.58%, which is quite impressive.
IVDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.33%.
Measured over the past years, IVDA shows a very strong growth in Revenue. The Revenue has been growing by 63.73% on average per year.
EPS 1Y (TTM)72.58%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-16.67%
Revenue 1Y (TTM)45.33%
Revenue growth 3Y63.73%
Revenue growth 5YN/A
Revenue growth Q2Q-51.6%

3.2 Future

The Earnings Per Share is expected to grow by 99.79% on average over the next years. This is a very strong growth
Based on estimates for the next years, IVDA will show a very strong growth in Revenue. The Revenue will grow by 118.64% on average per year.
EPS Next Y80.57%
EPS Next 2Y99.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year151.32%
Revenue Next 2Y118.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVDA. In the last year negative earnings were reported.
Also next year IVDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as IVDA's earnings are expected to grow with 99.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y99.79%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IVDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IVEDA SOLUTIONS INC

NASDAQ:IVDA (4/26/2024, 7:00:02 PM)

Premarket: 0.9499 +0.03 (+3.42%)

0.9185

+0.02 (+1.74%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.85M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.6%
ROE -54.88%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.06
Quick Ratio 3.84
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)72.58%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y80.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)45.33%
Revenue growth 3Y63.73%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y